{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T13:06:51Z","timestamp":1788527211684,"version":"build-2803163510"},"reference-count":125,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T00:00:00Z","timestamp":1585872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00489","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T12:12:29Z","timestamp":1585915949000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":142,"title":["Diagnosis and Treatment of VOD\/SOS After Allogeneic Hematopoietic Stem Cell Transplantation"],"prefix":"10.3389","volume":"11","author":[{"given":"Francesca","family":"Bonifazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Barbato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Ravaioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariarosaria","family":"Sessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Defrancesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Arpinati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Cavo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Colecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1182\/blood.V85.11.3005.bloodjournal85113005","article-title":"The syndrome of hepatic veno-occlusive disease after marrow transplantation","volume":"85","author":"Bearman","year":"1995","journal-title":"Blood."},{"key":"B2","doi-asserted-by":"publisher","first-page":"589","DOI":"10.4065\/78.5.589","article-title":"Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation","volume":"78","author":"Kumar","year":"2003","journal-title":"Mayo Clin Proc."},{"key":"B3","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.clinre.2016.01.006","article-title":"Sinusoidal obstruction syndrome","volume":"40","author":"Valla","year":"2016","journal-title":"Clin Res Hepatol Gastroenterol."},{"key":"B4","first-page":"584","article-title":"Pathogenesis of veno-occlusive liver disease after radiation","volume":"104","author":"Fajardo","year":"1980","journal-title":"Arch Pathol Lab Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1016\/j.transproceed.2014.09.110","article-title":"Severe veno-occlusive disease\/sinusoidal obstruction syndrome after deceased-donor and living-donor liver transplantation","volume":"46","author":"Takamura","year":"2014","journal-title":"Transplant Proc."},{"key":"B6","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/hep.1840040121","article-title":"Veno-occlusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors","volume":"4","author":"McDonald","year":"1984","journal-title":"Hepatology."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(11)61938-7","article-title":"Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial","volume":"379","author":"Corbacioglu","year":"2012","journal-title":"Lancet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/bmt.2009.56","article-title":"Severe hepatocellular injury after hematopoietic cell transplant: incidence, etiology and outcome","volume":"44","author":"Sakai","year":"2009","journal-title":"Bone Marrow Transplant."},{"key":"B9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","article-title":"Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome","volume":"16","author":"Coppell","year":"2010","journal-title":"Biol Blood Marrow Transplant."},{"key":"B10","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/bjh.13215","article-title":"How I manage sinusoidal obstruction syndrome after haematopoietic transplantation","volume":"168","author":"Carreras","year":"2015","journal-title":"Br J Haematol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/bmt.2011.65","article-title":"The role of the endothelium in the short-term complications of hematopoietic SCT","volume":"46","author":"Carreras","year":"2011","journal-title":"Bone Marrow Transplant."},{"key":"B12","first-page":"3599","article-title":"Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party","volume":"92","author":"Carreras","year":"1998","journal-title":"Blood."},{"key":"B13","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/bmt.2017.161","article-title":"Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation","volume":"53","author":"Corbacioglu","year":"2018","journal-title":"Bone Marrow Transplant."},{"key":"B14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/sj.bmt.1704069","article-title":"Incidence, survival and risk factors for the development of veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients","volume":"32","author":"Barker","year":"2003","journal-title":"Bone Marrow Transplant."},{"key":"B15","first-page":"1396","article-title":"A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation","volume":"90","author":"Cesaro","year":"2005","journal-title":"Haematologica."},{"key":"B16","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/bjh.15267","article-title":"Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease\/sinusoidal obstruction syndrome","volume":"181","author":"Kernan","year":"2018","journal-title":"Br J Haematol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1016\/j.bbmt.2016.07.001","article-title":"Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: Final Results from the International Compassionate-Use Program","volume":"22","author":"Corbacioglu","year":"2016","journal-title":"Biol Blood Marrow Transplant."},{"key":"B18","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/hep.510230326","article-title":"Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venoocclusive disease","volume":"23","author":"DeLeve","year":"1996","journal-title":"Hepatology."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1016\/j.transproceed.2010.04.024","article-title":"Vascular endothelium changes after conditioning in hematopoietic stem cell transplantation: role of cyclophosphamide and busulfan","volume":"42","author":"Zeng","year":"2010","journal-title":"Transplant Proc."},{"key":"B20","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.bbmt.2009.01.013","article-title":"The release of soluble factors contributing to endothelial activation and damage after hematopoietic stem cell transplantation is not limited to the allogeneic setting and involves several pathogenic mechanisms","volume":"15","author":"Palomo","year":"2009","journal-title":"Biol Blood Marrow Transplant."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1038\/sj.bmt.1701264","article-title":"Influence of bacterial endotoxin on the allogenicity of human endothelial cells","volume":"21","author":"Eissner","year":"1998","journal-title":"Bone Marrow Transplant."},{"key":"B22","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.exphem.2004.05.023","article-title":"G-CSF increases the expression of VCAM-1 on stromal cells promoting the adhesion of CD34+ hematopoietic cells: studies under flow conditions","volume":"32","author":"Fuste","year":"2004","journal-title":"Exp Hematol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.transproceed.2004.05.073","article-title":"Endothelial dysfunction in renal transplant patients is closely related to serum cyclosporine levels","volume":"36","author":"Mercanoglu","year":"2004","journal-title":"Transplant Proc."},{"key":"B24","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1055\/s-0038-1644123","article-title":"Cyclosporin-induced endothelial cell injury","volume":"55","author":"Zoja","year":"1986","journal-title":"Lab Invest."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1016\/S0140-6736(02)08907-9","article-title":"Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease","volume":"359","author":"Biedermann","year":"2002","journal-title":"Lancet."},{"key":"B26","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/sj.bmt.1702377","article-title":"The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy-related toxicity","volume":"25","author":"Hassan","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"B27","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1093\/carcin\/5.8.993","article-title":"Characterization, localization and regulation of a novel phenobarbital-inducible form of cytochrome P450, compared with three further P450-isoenzymes, NADPH P450-reductase, glutathione transferases and microsomal epoxide hydrolase","volume":"5","author":"Wolf","year":"1984","journal-title":"Carcinogenesis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/hep.510240414","article-title":"Cellular target of cyclophosphamide toxicity in the murine liver: role of glutathione and site of metabolic activation","volume":"24","author":"DeLeve","year":"1996","journal-title":"Hepatology."},{"key":"B29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000028359","article-title":"Role of oxidative stress and glutathione in busulfan toxicity in cultured murine hepatocytes","volume":"60","author":"DeLeve","year":"2000","journal-title":"Pharmacology."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1182\/blood-2003-11-3778","article-title":"Glutathione S-transferase M1 polymorphism: a risk factor for hepatic venoocclusive disease in bone marrow transplantation","volume":"104","author":"Srivastava","year":"2004","journal-title":"Blood."},{"key":"B31","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-02278-5","volume-title":"The EBMT Handbook.","author":"Carreras","year":"2019"},{"key":"B32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.beha.2008.02.003","article-title":"Vascular endothelium and graft-versus-host disease","volume":"21","author":"Biedermann","year":"2008","journal-title":"Best Pract Res Clin Haematol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/j.1582-4934.2008.00639.x","article-title":"Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence","volume":"13","author":"Sabatier","year":"2009","journal-title":"J Cell Mol Med."},{"key":"B34","first-page":"32","article-title":"Circulating endothelial precursor cells (EPC) in patients undergoing allogeneic haematopoietic progenitor cell transplantation","volume":"56","author":"Pytl\u00edk","year":"2010","journal-title":"Folia Biol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1097\/01.tp.0000209218.24916.ba","article-title":"Endothelial cell-derived microparticles in allogeneic hematopoietic stem cell recipients","volume":"81","author":"Pihusch","year":"2006","journal-title":"Transplantation."},{"key":"B36","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1002\/hep.1840380416","article-title":"Decreased hepatic nitric oxide production contributes to the development of rat sinusoidal obstruction syndrome","volume":"38","author":"DeLeve","year":"2003","journal-title":"Hepatology."},{"key":"B37","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/S0016-5085(03)01056-4","article-title":"Sinusoidal obstruction syndrome (veno-occlusive disease) in the rat is prevented by matrix metalloproteinase inhibition","volume":"125","author":"Deleve","year":"2003","journal-title":"Gastroenterology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1002\/ar.a.20092","article-title":"Innervation of the sinusoidal wall: regulation of the sinusoidal diameter","volume":"280","author":"Ueno","year":"2004","journal-title":"Anat Rec A Discov Mol Cell Evol Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1136\/gut.2007.133637","article-title":"Budd-Chiari syndrome and veno-occlusive disease\/sinusoidal obstruction syndrome","volume":"57","author":"Valla","year":"2008","journal-title":"Gut."},{"key":"B40","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jhep.2015.07.040","article-title":"EASL Clinical Practice Guidelines: Vascular diseases of the liver","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/bmt.2016.130","article-title":"Revised diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation","volume":"51","author":"Mohty","year":"2016","journal-title":"Bone Marrow Transplant."},{"key":"B42","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/bmt.2015.52","article-title":"Sinusoidal obstruction syndrome\/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT)","volume":"50","author":"Mohty","year":"2015","journal-title":"Bone Marrow Transplant."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.bbmt.2011.06.006","article-title":"The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade","volume":"17","author":"Carreras","year":"2011","journal-title":"Biol Blood Marrow Transplant."},{"key":"B44","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","article-title":"Venoocclusive disease of the liver following bone marrow transplantation","volume":"44","author":"Jones","year":"1987","journal-title":"Transplantation."},{"key":"B45","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.bbmt.2014.09.026","article-title":"Veno-occlusive disease of the liver in the absence of elevation in bilirubin in pediatric patients after hematopoietic stem cell transplantation","volume":"21","author":"Myers","year":"2015","journal-title":"Biol Blood Marrow Transplant."},{"key":"B46","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/bmt.2015.208","article-title":"Anicteric veno-occlusive disease after hematopoietic stem cell transplantation in children","volume":"51","author":"Naples","year":"2015","journal-title":"Bone Marrow Transplant."},{"key":"B47","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.bbmt.2018.09.027","article-title":"Sinusoidal Obstruction Syndrome\/Veno-Occlusive Disease after Autologous or Allogeneic Hematopoietic Stem Cell Transplantation in Children: a retrospective study of the Italian Hematology-Oncology Association-Hematopoietic Stem Cell Transplantation Group","volume":"25","author":"Faraci","year":"2019","journal-title":"Biol Blood Marrow Transplant."},{"key":"B48","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/s41409-019-0559-4","article-title":"Efficacy and safety of defibrotide in the treatment of hepatic veno-occlusive disease\/sinusoidal obstruction syndrome following hematopoietic stem cell transplantation: interim results from the defifrance study","volume":"54","author":"Mohty","year":"2019","journal-title":"Bone Marrow Transplant."},{"key":"B49","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1148\/radiology.204.2.9240551","article-title":"Hepatic veno-occlusive disease after myeloablative treatment and bone marrow transplantation: value of grayscale and Doppler US in 100 patients","volume":"204","author":"Lassau","year":"1997","journal-title":"Radiology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1007\/s00330-017-5137-9","article-title":"Gallbladder wall oedema and ascites are independent predictors of progression to hepatic veno-occlusive disease for children with hematopoietic stem celltransplantation","volume":"28","author":"Park","year":"2018","journal-title":"Eur Radiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1016\/j.bbmt.2018.05.025","article-title":"Novel ultrasonographic scoring system of sinusoidal obstruction syndrome after hematopoietic stem cell transplantation","volume":"24","author":"Nishida","year":"2018","journal-title":"Biol Blood Marrow Transplant."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.7863\/jum.2011.30.11.1593","article-title":"Acoustic radiation force impulse elastography and contrast-enhanced sonography of sinusoidal obstructive syndrome (Veno-occlusive Disease): preliminary results","volume":"30","author":"Fontanilla","year":"2011","journal-title":"J Ultrasound Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/s41409-018-0198-1","article-title":"Clinical diagnosis ofveno-occlusive disease using contrast enhanced ultrasound","volume":"53","author":"Trenker","year":"2018","journal-title":"Bone MarrowTransplant."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.3748\/wjg.v23.i10.1735","article-title":"Portal hypertension: Imaging of portosystemic collateral pathways and associated image-guided therapy","volume":"23","author":"Bandali","year":"2017","journal-title":"World J Gastroenterol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4274\/tjh.2016.0450","article-title":"Current review of iron overload and related complications in hematopoietic stem cell transplantation","volume":"34","author":"Atilla","year":"2017","journal-title":"Turk J Haematol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1080\/17474124.2019.1588111","article-title":"Role of imaging techniques in liver veno-occlusive disease diagnosis: recent advances and literature review","volume":"13","author":"Ravaioli","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jvir.2012.09.011","article-title":"Safety and utility of transjugular liver biopsy in hematopoietic stem cell transplant recipients","volume":"24","author":"Kis","year":"2013","journal-title":"J Vasc Interv Radiol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrgastro.2009.149","article-title":"The clinical use of HVPG measurements in chronic liver disease","volume":"6","author":"Bosch","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","article-title":"Transient elastography: a new noninvasive method for assessment of hepatic fibrosis","volume":"29","author":"Sandrin","year":"2003","journal-title":"Ultrasound Med Biol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1053\/j.gastro.2012.02.017","article-title":"Noninvasive methods to assess liver disease in patients with hepatitis B or C","volume":"142","author":"Castera","year":"2012","journal-title":"Gastroenterology."},{"key":"B61","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1053\/j.gastro.2012.05.035","article-title":"Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis","volume":"143","author":"Colecchia","year":"2012","journal-title":"Gastroenterology."},{"key":"B62","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/bmt.2016.320","article-title":"Usefulness of liver stiffness measurement in predicting hepatic veno-occlusive disease development in patients who undergo HSCT","volume":"52","author":"Colecchia","year":"2017","journal-title":"Bone Marrow Transplant."},{"key":"B63","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.bbmt.2019.01.019","article-title":"Liver stiffness measurement allows early diagnosis of veno-occlusive disease\/sinusoidal obstruction syndrome in adult patients who undergo hematopoietic stem cell transplantation: results from a monocentric prospective study","volume":"25","author":"Colecchia","year":"2019","journal-title":"Biol Blood Marrow Transplant."},{"key":"B64","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41409-017-0064-6","article-title":"Using liver elastography to diagnose sinusoidal obstruction syndrome in pediatric patients undergoing hematopoietic stem cell transplant","volume":"15","author":"Reddivalla","year":"2018","journal-title":"Bone Marrow Transplant."},{"key":"B65","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.jhep.2007.11.020","article-title":"Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome","volume":"48","author":"Roulot","year":"2008","journal-title":"J Hepatol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1055\/a-0641-0076","article-title":"EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017 (Long Version)","volume":"38","author":"Dietrich","year":"2017","journal-title":"Ultraschall Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/978-3-319-23018-4_1","article-title":"Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension","volume":"63","author":"De Franchis","year":"2015","journal-title":"J Hepatol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jhep.2017.02.003","article-title":"Non-invasive evaluation of portal hypertension using ultrasound elastography","volume":"67","author":"Berzigotti","year":"2017","journal-title":"J Hepatol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"e13456","DOI":"10.1111\/petr.13456","article-title":"Longitudinal evaluation of liver stiffness in three pediatric patients with veno-occlusive disease","volume":"23","author":"Zama","year":"2019","journal-title":"Pediatr Transplant."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.bbmt.2019.02.018","article-title":"Risk factors for development of and progression of hepatic veno-occlusive disease\/sinusoidal obstruction syndrome","volume":"25","author":"Corbacioglu","year":"2019","journal-title":"Biol Blood Marrow Transplant."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1046\/j.1365-2141.2002.03748.x","article-title":"Plasminogen activator inhibitor-1 is an independent diagnostic marker as well as severity predictor of hepatic veno-occlusive disease after allogeneic bone marrow transplantation in adults conditioned with busulphan and cyclophosphamide","volume":"118","author":"Lee","year":"2002","journal-title":"Br J Haematol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1097\/01.tp.0000183288.67746.44","article-title":"Diagnosis of hepatic veno-occlusive disease by plasminogen activator inhibitor-1 plasma antigen levels: a prospective analysis in 350 allogeneic hematopoietic stem cell recipients","volume":"80","author":"Pihusch","year":"2005","journal-title":"Transplantation."},{"key":"B73","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/pbc.23213","article-title":"Contribution of fibrinolytic tests to the differential diagnosis of veno-occlusive disease complicating pediatric hematopoietic stem cell transplantation","volume":"58","author":"Sartori","year":"2012","journal-title":"Pediatr Blood Cancer."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1111\/imj.13550","article-title":"New insights into sinusoidal obstruction syndrome","volume":"47","author":"Piccin","year":"2017","journal-title":"Intern Med J."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.bbmt.2010.02.009","article-title":"Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial","volume":"16","author":"Richardson","year":"2010","journal-title":"Biol Blood Marrow Transplant."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.bbmt.2015.07.004","article-title":"Biomarkers for diagnosis and prognosis of sinusoidal obstruction syndrome after hematopoietic cell transplantation","volume":"21","author":"Akil","year":"2015","journal-title":"Biol Blood Marrow Transplant."},{"key":"B77","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.bbmt.2015.09.024","article-title":"Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: risk factors and stratification, prophylaxis, and treatment","volume":"22","author":"Dalle","year":"2016","journal-title":"Biol Blood Marrow Transplant."},{"key":"B78","doi-asserted-by":"publisher","first-page":"e387","DOI":"10.1016\/S2352-3026(17)30103-5","article-title":"Hepatic adverse event profile of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukaemia: results from the open-label, randomised, phase 3 INO-VATE study","volume":"4","author":"Kantarjian","year":"2017","journal-title":"Lancet Haematol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1056\/NEJMc1612040","article-title":"Inotuzumab ozogamicin for acute lymphoblastic leukemia","volume":"375","author":"Kantarjian","year":"2016","journal-title":"N Engl J Med."},{"key":"B80","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41409-017-0019-y","article-title":"Management of important adverse events associated with inotuzumab ozogamicin: expert panel review","volume":"53","author":"Kebriaei","year":"2018","journal-title":"Bone Marrow Transplant."},{"key":"B81","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1016\/j.bbmt.2018.06.013","article-title":"Risk score for the development of veno-occlusive disease after allogeneic hematopoietic cell transplant","volume":"24","author":"Strouse","year":"2018","journal-title":"Biol Blood Marrow Transplant."},{"key":"B82","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3332\/ecancer.2016.661","article-title":"Veno-occlusive disease nurse management: development of a dynamic monitoring tool by the GITMO nursing group","volume":"10","author":"Botti","year":"2016","journal-title":"Ecancermedicalscience."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1182\/bloodadvances.2017008375","article-title":"The use of defibrotide in blood and marrow transplantation","volume":"2","author":"Richardson","year":"2018","journal-title":"Blood Adv."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vph.2013.05.001","article-title":"Defibrotide: properties and clinical use of an old\/new drug","volume":"59","author":"Pescador","year":"2013","journal-title":"Vascul Pharmacol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1182\/blood.V100.1.334","article-title":"Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide","volume":"100","author":"Eissner","year":"2002","journal-title":"Blood."},{"key":"B86","first-page":"100","article-title":"Effects of defibrotide in patients with chronic deep insufficiency. The PROVEDIS study","volume":"23","author":"Coccheri","year":"2004","journal-title":"Int Angiol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000215340","article-title":"Defibrotide therapy for thrombophlebitis\u2013controlled clinical trial","volume":"16","author":"Di Perri","year":"1986","journal-title":"Haemostasis Suppl"},{"key":"B88","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000215338","article-title":"Effectiveness of defibrotide for prophylaxis of deep venous thrombosis after general surgery: a double-blind, placebo-controlled clinical trial","volume":"1","author":"Mozzi","year":"1986","journal-title":"Haemostasis. Suppl."},{"key":"B89","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1159\/000215339","article-title":"Effectiveness of defibrotide for prophylaxis of deep venous thrombosis in gynecological surgery: a double-blind, placebo-controlled clinical trial","volume":"1","author":"Ciavarella","year":"1986","journal-title":"Haemostasis. Suppl."},{"key":"B90","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/0268-9499(90)90075-U","article-title":"Effects of defibrotide after oral and parenteral administration in patients with peripheral obliterative arterial disease (POAD)","volume":"9","author":"Craveri","year":"1990","journal-title":"Int Angiol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1055\/s-2007-1002745","article-title":"Use of defibrotide in the treatment of acute myocardial infarction","volume":"15","author":"Milazzotto","year":"1989","journal-title":"Semin Thromb Hemost."},{"key":"B92","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/BF00878935","article-title":"Defibrotide versus heparin in the prevention of coronary reocclusion after thrombolysis in acute myocardial infarction","volume":"7","author":"Tubaro","year":"1993","journal-title":"Cardiovasc Drugs Ther."},{"key":"B93","first-page":"179","article-title":"Defibrotide, a stimulator of prostacyclin (PGI2) production, prevents the effects of ischaemic damage","volume":"11","author":"Ferrero","year":"1989","journal-title":"Int J Tissue React."},{"key":"B94","first-page":"29","article-title":"Clinical trials with defibrotide in vascular disorders","volume":"1","author":"Cimminiello","year":"1996","journal-title":"Semin Thromb Hemost. Suppl."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1182\/blood-2015-10-676924","article-title":"Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure","volume":"127","author":"Richardson","year":"2016","journal-title":"Blood."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1200\/JCO.1993.11.9.1729","article-title":"Veno-occlusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation","volume":"11","author":"Bearman","year":"1993","journal-title":"J Clin Oncol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1038\/s41409-019-0474-8","article-title":"Systematic review of defibrotide studies in the treatment of veno-occlusive disease\/sinusoidal obstruction syndrome (VOD\/SOS)","volume":"54","author":"Richardson","year":"2019","journal-title":"Bone Marrow Transplant."},{"key":"B98","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/sj.bmt.1705896","article-title":"Successful treatment of hepatic veno-occlusive disease after myeloablative allogeneic hematopoietic stem cell transplantation by early administration of a short course of methylprednisolone","volume":"41","author":"Al Beihany","year":"2008","journal-title":"Bone Marrow Transplant."},{"key":"B99","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.bbmt.2012.11.011","article-title":"High-dose methylprednisolone for veno-occlusive disease of the liver in pediatric hematopoietic stem cell transplantation recipients","volume":"19","author":"Myers","year":"2013","journal-title":"Biol Blood Marrow Transplant."},{"key":"B100","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/bjh.12558","article-title":"BCSH\/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following hematopoietic stem cell transplantation","volume":"163","author":"Dignan","year":"2013","journal-title":"Br J Haematol."},{"key":"B101","first-page":"643","article-title":"Transjugular intrahepatic portosystemic shunting (TIPS) for treatment of severe hepatic veno-occlusive disease","volume":"18","author":"Smith","year":"1996","journal-title":"Bone Marrow Transplant."},{"key":"B102","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/lt.22351","article-title":"Transjugular intrahepatic portosystemic shunt for the treatment of sinusoidal obstruction syndrome in a liver transplant recipient and review of the literature","volume":"18","author":"Campos-Varela","year":"2012","journal-title":"Liver Transpl."},{"key":"B103","first-page":"421","article-title":"Orthotopic liver transplantation for life-threatening veno-occlusive disease of the liver after allogeneic bone marrow transplant","volume":"8","author":"Rapoport","year":"1991","journal-title":"Bone Marrow Transplant."},{"key":"B104","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1600-0609.1991.tb01859.x","article-title":"Prophylactic heparin does not prevent liver veno-occlusive disease following autologous bone marrow transplantation","volume":"47","author":"Marsa-Vila","year":"1991","journal-title":"Eur J Haematol."},{"key":"B105","first-page":"407","article-title":"A pilot study of continuous infusion heparin for the prevention of hepatic veno-occlusive disease after bone marrow transplantation","volume":"5","author":"Bearman","year":"1990","journal-title":"Bone Marrow Transplant."},{"key":"B106","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/sj.bmt.1705297","article-title":"Use of prophylactic anticoagulation and the risk of hepatic veno-occlusive disease in patients undergoing hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"37","author":"Imran","year":"2006","journal-title":"Bone Marrow Transplant."},{"key":"B107","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/sj.bmt.1702854","article-title":"Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecular weight heparin","volume":"27","author":"Simon","year":"2001","journal-title":"Bone Marrow Transplant."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/sj.bmt.1704087","article-title":"Low molecular weight heparin for the prevention of hepatic veno-occlusive disease (VOD\/SOS) after hematopoietic stem cell transplantation: a prospective phase II study","volume":"31","author":"Forrest","year":"2003","journal-title":"Bone Marrow Transplant."},{"key":"B109","first-page":"795","article-title":"Hepatic veno-occlusive disease in pediatric stem cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III\/defibrotide therapy","volume":"91","author":"Haussmann","year":"2006","journal-title":"Haematologica."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/sj.bmt.1701023","article-title":"Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications","volume":"20","author":"Ferr\u00e0","year":"1997","journal-title":"Bone Marrow Transplant."},{"key":"B111","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1182\/blood.V82.3.732.732","article-title":"Prevention of regimen-related toxicities after bone marrow transplantation by pentoxifylline: a prospective, randomized trial","volume":"82","author":"Attal","year":"1993","journal-title":"Blood."},{"key":"B112","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3346\/jkms.2006.21.5.897","article-title":"Prophylactic low-dose heparin or prostaglandin E1 may prevent severe veno-occlusive disease of the liver after allogeneic hematopoietic stem cell transplantation in Korean children","volume":"21","author":"Song","year":"2006","journal-title":"J Korean Med Sci."},{"key":"B113","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/j.1365-2141.1993.tb03152.x","article-title":"A phase I\/II study of prostaglandin E1 for the prevention of hepatic venocclusive disease after bone marrow transplantation","volume":"84","author":"Bearman","year":"1993","journal-title":"Br J Haematol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1365-2141.1990.tb02583.x","article-title":"Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation","volume":"74","author":"Gluckman","year":"1990","journal-title":"Br J Haematol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"975","DOI":"10.7326\/0003-4819-128-12_Part_1-199806150-00002","article-title":"Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial","volume":"128","author":"Essell","year":"1998","journal-title":"Ann Intern Med."},{"key":"B116","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/(SICI)1096-8652(200005)64:1<32::AID-AJH6>3.0.CO;2-N","article-title":"The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation","volume":"64","author":"Ohashi","year":"2000","journal-title":"Am J Hematol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1182\/blood-2001-12-0159","article-title":"Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation","volume":"100","author":"Ruutu","year":"2002","journal-title":"Blood."},{"key":"B118","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.bbmt.2006.09.012","article-title":"Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation","volume":"13","author":"Tay","year":"2007","journal-title":"Biol Blood Marrow Transplant."},{"key":"B119","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/sj.bmt.1703342","article-title":"A randomized trial of heparin plus ursodiol vs. heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation","volume":"29","author":"Park","year":"2002","journal-title":"Bone Marrow Transplant."},{"key":"B120","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/sj.bmt.1705485","article-title":"Stem cell transplantation in children with infantile osteopetrosis is associated with a high incidence of VOD\/SOS, which could be prevented with defibrotide","volume":"38","author":"Corbacioglu","year":"2006","journal-title":"Bone Marrow Transplant."},{"key":"B121","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/pbc.21425","article-title":"Defibrotide in the prevention and treatment of veno-occlusive disease in autologous and allogeneic stem cell transplantation in children","volume":"50","author":"Qureshi","year":"2008","journal-title":"Pediatr Blood Cancer."},{"key":"B122","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/j.1365-2141.2009.07871.x","article-title":"Absence of VOD\/SOS in paediatric thalassaemic HSCT recipients using defibrotide prophylaxis and intravenous Busulphan","volume":"147","author":"Cappelli","year":"2009","journal-title":"Br J Haematol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.bbmt.2004.01.002","article-title":"Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation","volume":"10","author":"Chalandon","year":"2004","journal-title":"Biol Blood Marrow Transplant."},{"key":"B124","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/sj.bmt.1705696","article-title":"Prophylactic defibrotide in allogeneic stem cell transplantation: minimal morbidity and zero mortality from veno-occlusive disease","volume":"40","author":"Dignan","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"B125","doi-asserted-by":"publisher","first-page":"36","DOI":"10.12659\/AOT.883811","article-title":"Safety and effects of prophylactic defibrotide for sinusoidal obstruction syndrome in hematopoietic stem cell transplantation","volume":"18","author":"Park","year":"2013","journal-title":"Ann Transplant."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00489\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T12:12:35Z","timestamp":1585915955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00489\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,3]]},"references-count":125,"alternative-id":["10.3389\/fimmu.2020.00489"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00489","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,3]]},"article-number":"489"}}